West Pharmaceutical Services, Inc. P/E Ratio 2008–2025
West Pharmaceutical Services, Inc. reported 40.43 of price-to-earnings ratio for fiscal 2025. That was 17.0% lower than fiscal 2024. Compared with fiscal 2020, the change was -33.8%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 40.43 | -17.0% |
| FY 2024 | 48.69 | +9.8% |
| FY 2023 | 44.33 | +47.1% |
| FY 2022 | 30.13 | -43.6% |
| FY 2021 | 53.41 | -12.6% |
| FY 2020 | 61.09 | +32.8% |
| FY 2019 | 46.00 | +31.6% |
| FY 2018 | 34.97 | -27.4% |
| FY 2017 | 48.18 | +12.3% |
| FY 2016 | 42.90 | -3.4% |
| FY 2015 | 44.43 | +53.5% |
| FY 2014 | 28.94 | -1.7% |
| FY 2013 | 29.46 | +32.8% |
| FY 2012 | 22.19 | +37.7% |
| FY 2011 | 16.11 | -18.1% |
| FY 2010 | 19.67 | +19.9% |
| FY 2009 | 16.40 | +24.5% |
| FY 2008 | 13.17 | — |
Source: West Pharmaceutical Services, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open WST 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
West Pharmaceutical Services, Inc. reported 40.43 of price-to-earnings ratio for fiscal 2025. That was 17.0% lower than fiscal 2024. Compared with fiscal 2020, the change was -33.8%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for West Pharmaceutical Services, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeWest Pharmaceutical Services, Inc. — frequently asked questions
What is West Pharmaceutical Services, Inc.'s price-to-earnings ratio?
West Pharmaceutical Services, Inc. (WST) reported price-to-earnings ratio of 40.43 for fiscal year 2025, per its SEC filings.
How has West Pharmaceutical Services, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2008 and 2025, WST's price-to-earnings ratio grew at roughly 6.8% per year (compound annual rate), from 13.17 to 40.43.
Where does this data come from?
Figures are computed from West Pharmaceutical Services, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More WST financial history
Full WST fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →